United States · FDA National Drug Code directory
Symvess
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83564-110_2ca3c2b8-a86b-4e5e-894a-6529e03052e0
- Product NDC
- 83564-110
- Form
- IMPLANT
- Composition / generic term
- ACELLULAR TISSUE ENGINEERED VESSEL
- Labeler
- Humacyte Global, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20241219
- Source listing expiry
- 20261231
Source-listed ingredients
- ACELLULAR TISSUE ENGINEERED VESSEL — 420 mm/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOX in 1 BAG (83564-110-00) / 1 IMPLANT in 1 BOX (83564-110-01) · 83564-110-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →